Literature DB >> 11258648

Effects of topical budesonide treatment on glucocorticoid receptor mRNA down-regulation and cytokine patterns in nasal polyps.

G Henriksson1, T Norlander, J Forsgren, P Stierna.   

Abstract

UNLABELLED: The effects of a topically applied corticosteroid, budesonide, on the expression of glucocorticoid receptor (GR) mRNA and regulation of pro-inflammatory cytokine patterns in patients with nasal polyps were evaluated. All patients were eligible for surgical polypectomy, and a majority of them had been treated with nasal steroids. Patients were given 400 microg b.i.d. (group A, n = 11), 200 microg b.i.d. (group B, n = 10), or no treatment (group C, n = 15) during two months before polypectomy. Morning serum cortisol was analyzed on the day of surgery. Surgically removed polyps were taken for analysis of GR mRNA expression by solution hybridization. Remaining tissue was cryostat-sectioned, whereafter quantification of the cytokines interleukin 1beta, interleukin 2, interleukin 4, interleukin 5, interleukin 6, interleukin 10, tumor necrosis factor alpha, and interferon gamma was made by immunohistochemistry and digitized image analysis. No significant differences among the three groups were found for any of the parameters investigated.
CONCLUSION: nasal polyps do not respond with down-regulation of GR mRNA or cytokines following topical corticosteroid treatment. The proposed corticosteroid resistance may be inherent, or induced by a change of local tissue bioavailability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11258648     DOI: 10.2500/105065801781329446

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  6 in total

Review 1.  Alpha and beta glucocorticoid receptors: relevance in airway diseases.

Authors:  Laura Pujols; Joaquim Mullol; César Picado
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

Review 2.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Glucocorticoid receptor isoform expression in peripheral blood mononuclear leukocytes of patients with chronic rhinosinusitis.

Authors:  Robert J Taylor; Rodney J Schlosser; Zachary M Soler; Jose L Mattos; Jennifer K Mulligan
Journal:  Int Forum Allergy Rhinol       Date:  2018-05-02       Impact factor: 3.858

4.  The Role of NF-κB in Chronic Rhinosinusitis With Nasal Polyps.

Authors:  Hahn Jin Jung; Yu Lian Zhang; Dong Kyu Kim; Chae Seo Rhee; Dong Young Kim
Journal:  Allergy Asthma Immunol Res       Date:  2019-11       Impact factor: 5.764

5.  Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles.

Authors:  Hisako Ibaraki; Takanori Kanazawa; Minami Owada; Keiko Iwaya; Yuuki Takashima; Yasuo Seta
Journal:  Pharmaceutics       Date:  2020-01-15       Impact factor: 6.321

6.  In vitro effect of glucocorticoids on nasal polyps.

Authors:  Fabiana Valera; María S Brassesco; Angel M Castro-Gamero; Maria A Cortez; Rosane G P Queiroz; Luiz G Tone; Wilma T Anselmo-Lima
Journal:  Braz J Otorhinolaryngol       Date:  2011 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.